Neil Almstead
2016
In 2016, Neil Almstead earned a total compensation of $1.6M as Executive Vice President, Research, Pharmaceutical Operations & Technology at PTC Therapeutics, a 42% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,582 |
|---|---|
| Option Awards | $1,054,400 |
| Salary | $422,300 |
| Other | $8,566 |
| Total | $1,628,847 |
Almstead received $1.1M in option awards, accounting for 65% of the total pay in 2016.
Almstead also received $143.6K in non-equity incentive plan, $422.3K in salary and $8.6K in other compensation.
Rankings
In 2016, Neil Almstead's compensation ranked 5,866th out of 14,075 executives tracked by ExecPay. In other words, Almstead earned more than 58.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,866 out of 14,075 | 58th |
Division Manufacturing | 2,125 out of 5,488 | 61st |
Major group Chemicals And Allied Products | 696 out of 1,900 | 63rd |
Industry group Drugs | 525 out of 1,543 | 66th |
Industry Pharmaceutical Preparations | 416 out of 1,173 | 65th |
Source: SEC filing on April 27, 2017.
Almstead's colleagues
We found four more compensation records of executives who worked with Neil Almstead at PTC Therapeutics in 2016.